Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
V. Ellenrieder, W. Boeck, C. Richter, R. Marre, G. Adler, B. Glasbrenner. (1999) Prevalence of Resistance to Clarithromycin and Its Clinical Impact on the Efficacy of Helicobacter pylori Eradication. Scandinavian Journal of Gastroenterology 34:8, pages 750-756.
Read now
Read now
J Holton, C Besset, P Youinou & D Vaira. (1998) Emerging therapeutic targets in the eradication of Helicobacter pylori. Emerging Therapeutic Targets 2:2, pages 107-123.
Read now
Read now
Articles from other publishers (15)
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Edoardo Giovanni Giannini & Edoardo Vincenzo Savarino. (2023) Gastrointestinal functional disorders can benefit from the use of medical devices made of substances. Frontiers in Drug Safety and Regulation 3.
Crossref
Crossref
Yuan Wenzhen, Li Yumin, Guan Quanlin, Yang Kehu, Jiang Lei, Wang Donghai & Yang Lijuan. (2010) Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-. Internal Medicine 49:12, pages 1103-1109.
Crossref
Crossref
Yuan Wenzhen, Yang Kehu, Ma Bin, Li Yumin, Guan Quanlin, Wang Donghai & Yang Lijuan. (2009) Moxifloxacin-Based Triple Therapy Versus Clarithromycin-Based Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials. Internal Medicine 48:24, pages 2069-2076.
Crossref
Crossref
E. C. Nista, M. Candelli, M. A. Zocco, I. A. Cazzato, F. Cremonini, V. Ojetti, M. Santoro, R. Finizio, G. Pignataro, G. Cammarota, G. Gasbarrini & A. Gasbarrini. (2005) Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 21:10, pages 1241-1247.
Crossref
Crossref
V. Ojetti, A. Migneco, M. A. Zocco, E. C. Nista, G. Gasbarrini & A. Gasbarrini. (2004) Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. Journal of Internal Medicine 255:1, pages 125-129.
Crossref
Crossref
X. Calvet & E. Gené. (2003) Erradicar Helicobacter pylori.¿Terapia triple o cuádruple?, ¿corta o larga?. Gastroenterología y Hepatología 26:5, pages 325-329.
Crossref
Crossref
S. Di Caro, V. Ojetti, M. A. Zocco, F. Cremonini, F. Bartolozzi, M. Candelli, A. Lupascu, E. C. Nista, G. Cammarota & A. Gasbarrini. (2002)
Mono, dual and triple moxifloxacin‐based therapies for
Helicobacter pylori
eradication
. Alimentary Pharmacology & Therapeutics 16:3, pages 527-532.
Crossref
Crossref
Ahmed Madisch, Jürgen Hotz, Gabriele Grabowski, Angelika Guth, Peter Malfertheiner, Klaus Plein & Berthold Schneider. (2002) Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study. European Journal of Gastroenterology & Hepatology 14:1, pages 61-69.
Crossref
Crossref
A. Bühling, D. Radun, W. A. Müller & P. Malfertheiner. (2001)
Influence of anti-
Helicobacter
triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora
. Alimentary Pharmacology & Therapeutics 15:9, pages 1445-1452.
Crossref
Crossref
Xavier Calvet, Llùcia Titó, Ricard Comet, Neus García, Ralel CampoEnric Brullet. (2001)
Four‐Day, Twice Daily, Quadruple Therapy with Amoxicillin, Clarithromycin, Tinidazole and Omeprazole to Cure
Helicobacter pylori
Infection: A Pilot Study
. Helicobacter 5:1, pages 52-56.
Crossref
Crossref
C. J. Hawkey. 2000. Helicobacter pylori. Helicobacter pylori
637
642
.
X. Calvet, M. -T. López-Lorente, M.-J Cubells, M Barè, E. Gálvez & E. Molina. (1999)
Two-week dual vs. one-week triple therapy for cure of
Helicobacter pylori
infection in primary care: a multicentre, randomized trial
. Alimentary Pharmacology & Therapeutics 13:6, pages 781-786.
Crossref
Crossref
Ellenrieder, Fensterer, Waurick, Adler & Glasbrenner. (1998) Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. Alimentary Pharmacology & Therapeutics 12:7, pages 613-618.
Crossref
Crossref
X Calvet, N García, R Campo, E Brullet, R Comet & M Navarro. (1998) Two-Day Quadruple Therapy for Cure of Helicobacter pylori Infection: A Comparative, Randomized Trial. American Journal of Gastroenterology 93:6, pages 932-934.
Crossref
Crossref
Georg Oberhuber, Thomas Wuendisch, Sigrid Rappel & Manfred Stolte. (1998) Significant Improvement of Atrophy after Eradication Therapy in Atrophic Body Gastritis. Pathology - Research and Practice 194:9, pages 609-613.
Crossref
Crossref